BioPharmGuy logo
Sponsored By:
Trianni Inc.
BioPharmGuy Database
Emery Pharma
Xlumena is defunct.

Fate: Acquired by Boston Scientific April 2015, $62.5M


------------------
If you believe any of this information is incorrect, please let us know.